Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVRx, Inc.CVRX · Entity 6920 | CHIEF FINANCIAL OFFICER | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVRx, Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 96,703 |
Ending reported balance
After 2026-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-27 · Grant · Acquired 61,000 · Balance 98,447 F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Row 2 · 2026-03-02 · Sale · Disposed 1,744 · Balance 96,703 F2: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. F3: Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2036-02-26 | Direct | 91,000 |
Reported balance
After 2026-02-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-27 · Grant · Acquired 91,000 · Balance 91,000 F4: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
F2: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.
F3: Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 3, 2026 18:02 UTC | CVRx, Inc. CVRX · Entity 6920 | SaleCommon Stock | 1,744 | $7.90 | $13,781.44 |
DisclosureSEC source: 0001869707-26-000002 · form4-03032026_110313.xml · nonDerivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,703 F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. F3 · price: Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 18:02 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 91,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001869707-26-000002 · form4-03032026_110313.xml · derivative · entry 3 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,000 Underlying: Common Stock · 91,000 shares Expires 2036-02-26 F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 18:02 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 61,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001869707-26-000002 · form4-03032026_110313.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,447 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006483 · form4-03042025_090345.xml · derivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006483 · form4-03042025_090345.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,447 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 17:38 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 55,500 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001415889-24-002838 · form4-02062024_100229.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,500 Underlying: Common Stock · 55,500 shares Expires 2034-02-01 F1 · derivative.exercise_date: Vests as to 25% of the shares on February 2, 2025 and as to 1/48th of the shares each month thereafter. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 16:04 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 5,335 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001415889-23-013458 · form4-09202023_080953.xml · derivative · entry 4 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,732 Underlying: Common Stock · 5,335 shares Expires 2029-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares on each month thereafter. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 16:04 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 527 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-23-013458 · form4-09202023_080953.xml · derivative · entry 3 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 527 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 16:04 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 5,335 | $3.96 | $21,099.93 |
DisclosureSEC source: 0001415889-23-013458 · form4-09202023_080953.xml · nonDerivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 16:04 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 527 | $0.24 | $124.90 |
DisclosureSEC source: 0001415889-23-013458 · form4-09202023_080953.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 19:12 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001415889-23-001285 · form4-01212023_120148.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2024 and as to 1/48th of the shares each month thereafter. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 19:40 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.01 | $0.00 |
DisclosureSEC source: 0001415889-22-008281 · form4-08042022_040817.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-08-01 F1 · derivative.exercise_date: Vests as to 25% of the shares on August 2, 2023 and as to 1/48th of the shares each month thereafter. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 2,633 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 8 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527 Underlying: Common Stock · 2,633 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 3,160 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 7 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,160 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 2,528 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 6 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,528 shares Expires 2026-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionStock Option (right to buy) · Derivative | 1,264 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · derivative · entry 5 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,264 shares Expires 2025-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 2,633 | $0.24 | $624.02 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 4 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 3,160 | $0.24 | $748.92 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 3 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 2,528 | $0.24 | $599.14 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 16:18 UTC | CVRx, Inc. CVRX · Entity 6920 | Exercise / conversionCommon Stock | 1,264 | $0.24 | $299.57 |
DisclosureSEC source: 0001415889-22-006157 · form4-06062022_010658.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 18:14 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 56,200 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001179110-22-000547 · edgar.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,200 Underlying: Common Stock · 56,200 shares Expires 2032-01-17 F1 · derivative.exercise_date: Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter. Read SEC document |
| June 29, 2021 Filed Jul 1, 2021 17:29 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 36,700 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007267 · edgar.xml · derivative · entry 1 OASHEIM JARED · CIK 0001869707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,700 Underlying: Common Stock · 36,700 shares Expires 2031-06-28 F1 · derivative.exercise_date: Vests as to 25% of the shares on June 29, 2022 and as to 1/48th of the shares each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.